SCHEMBL739914

SCHEMBL739914

CC(C)(NC(=O)c1cc2c(NC(=O)c3ccc(CN4CCC(F)CC4)cc3)n[nH]c2s1)c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.64
BCR P11274 2/20 0.64
AURKA O14965 3/20 0.51
ACKR3 P25106 2/20 0.47
KIT P10721 1/20 0.44
FLT3 P36888 1/20 0.44
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
HIF1A Q16665 1/20 0.42
EPAS1 Q99814 1/20 0.42
LMNA P02545 2/20 0.41
CYP2C9 P11712 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
MAOB P27338 1/20 0.39
HDAC1 Q13547 1/20 0.39
KDR P35968 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL740623 0.92 ABL1 (0.72) ABL1BCRAURKAACKR3KIT
SCHEMBL742638 0.92 ABL1 (0.74) ABL1BCRAURKAACKR3KIT
SCHEMBL742258 0.92 ABL1 (0.65) ABL1BCRAURKAFLT3MEN1
SCHEMBL740752 0.91 ABL1 (0.76) ABL1BCRAURKAACKR3KIT
SCHEMBL739604 0.91 ABL1 (0.66) ABL1BCRAURKAACKR3KIT
SCHEMBL741183 0.91 ABL1 (0.76) ABL1BCRAURKAACKR3KIT
SCHEMBL740990 0.91 ABL1 (0.65) ABL1BCRAURKAACKR3KIT
SCHEMBL743125 0.91 ABL1 (0.65) ABL1BCRAURKAACKR3KIT
SCHEMBL743704 0.89 ABL1 (0.64) ABL1BCRAURKAACKR3KIT
SCHEMBL742370 0.88 ABL1 (0.61) ABL1BCRAURKAACKR3KIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed